54 results on '"Scheetz, Marc"'
Search Results
2. 2946. Comparative Pharmacokinetics and Pharmacodynamics of Cefadroxil and Cephalexin for Pediatric Musculoskeletal Infections
3. Individual target pharmacokinetic/pharmacodynamic attainment rates among meropenem-treated patients admitted to the ICU with hospital-acquired pneumonia
4. Nephrotoxin Stewardship Alongside Antimicrobial Stewardship
5. 743. Implementation of Beta-Lactam Therapeutic Drug Monitoring Programs in the Critically Ill: A Multicenter Mixed-Methods Study
6. 967. Safety Outcomes of a Hospital-wide β-Lactam Graded Challenge Allergy Protocol
7. Does calculation method matter for targeting vancomycin area under the curve?
8. Associations Between Vancomycin Exposure and Acute Kidney Injury Within the Recommended Area Under the Curve Therapeutic Exposure Range Among Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
9. 1090. Does calculation method matter for targeting vancomycin AUC?
10. Precision dosing of vancomycin: in defence of AUC-guided therapy in children
11. Stability and Validation of a High-Throughput LC-MS/MS Method for the Quantification of Cefepime, Meropenem, and Piperacillin and Tazobactam in Serum
12. The case for precision dosing: medical conservatism does not justify inaction
13. Early Switch From Vancomycin to Daptomycin in Methicillin-Resistant Staphylococcus aureus Bacteremia: Still More Questions Than Answers
14. Vancomycin Duration of Therapy Can Inform the Need for Area Under the Curve Monitoring
15. 238. Novel Way to Evaluate Antibiotic Use Appropriateness: Moving Towards the “Never Event” Classification by Electronic Algorithm
16. Vancomycin: The pendulum swings
17. Lack of synergistic nephrotoxicity between vancomycin and piperacillin/tazobactam in a rat model and a confirmatory cellular model
18. Piperacillin-Tazobactam Added to Vancomycin Increases Risk for Acute Kidney Injury: Fact or Fiction?
19. β-Lactam pharmacodynamics in Gram-negative bloodstream infections in the critically ill
20. 1569. A Translational Model to Assess the Impact of Polymyxin B Dose Fractionation on Kidney Injury
21. 2010. A Significant Reduction in Empiric Vancomycin Days of Therapy for Suspected MRSA Pneumonia in Adult Non-ICU Patients After Implementation of a Rapid MRSA Nasal PCR Test with Antimicrobial Stewardship Intervention
22. 2000. Utilization of a ‘Never Event’ Framework to Classify Antimicrobial Appropriateness
23. 1573. Population Pharmacokinetic Analyses for Cefepime in Adult and Pediatric Patients
24. 1548. Characterizing Cefepime Neurotoxicity: Experience from a Tertiary Care Center Performing β-lactam Therapeutic Drug Monitoring
25. 1335. A Translational Nephrotoxicity Model to Probe Acute Kidney Injury with Vancomycin and Piperacillin–Tazobactam
26. Mechanisms of antimicrobial-induced nephrotoxicity in children
27. The Emperor’s New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With Methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE)
28. Twenty-four hour pharmacokinetic relationships for intravenous vancomycin and novel urinary biomarkers of acute kidney injury in a rat model
29. Vancomycin Area Under the Curve and Acute Kidney Injury: A Meta-analysis
30. 1068. Evaluation of Cefazolin vs. Anti-Staphylococcal Penicillins for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections in Acutely-Ill Adult Patients: Results of a Systematic Review and Meta-Analysis
31. 209. Impact of a Risk-based CAP Prescribing Guideline Paired with Antimicrobial Stewardship to Improve Antibiotic Prescribing for Patients at Low Risk for Drug-Resistant Pathogens
32. 1821. Understanding the Components and Calculation of the SAAR, Illustrative Data
33. 1394. A Translational Pharmacokinetic Rat Model of Cerebral Spinal Fluid (CSF) and Plasma Concentrations of Cefepime
34. 1391. Vancomycin Area Under the Curve (AUC) to Predict Nephrotoxicity: A Systematic Review and Meta-Analysis of Observational Studies
35. 1419. 24-Hour Pharmacokinetic Relationships for Intravenous Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury
36. 1871. Identifying Time Periods of High and Low Vancomycin Use
37. Measuring the impact of varying denominator definitions on standardized antibiotic consumption rates: implications for antimicrobial stewardship programmes
38. The Emperor’s New Clothes: Prospective Observational Evaluation of the Association between the Day 2 Vancomycin Exposure and Failure Rates among Adult Hospitalized Patients with MRSA Bloodstream Infections (PROVIDE)
39. Pharmacokinetics of centhaquin citrate in a dog model
40. Visual and absorbance analyses of admixtures containing vancomycin and piperacillin–tazobactam at commonly used concentrations
41. The Prevalence of an Inoculum Effect With Cefazolin and the Association With Certain blaZ Gene Types Among Methicillin-Susceptible Staphylococcus aureus Isolates From Four Major Chicago Medical Centers
42. Epidemiological Assessment of the Association Between Antibiotic Consumption and Clostridium difficile Incidence at an Academic Medical Center
43. Pharmacokinetics of centhaquin citrate in a rat model
44. Development of a pharmacy student research program at a large academic medical center
45. Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxis
46. Knowledge and Attitudes of Doctor of Pharmacy Students Regarding the Appropriate Use of Antimicrobials
47. 191Evaluation of Oxacillin Consumption Following Implementation of a Usage Restriction Protocol: A Drug Use Evaluation and Cost Savings Analysis
48. 1395Reporting of Unit-Specific, Culture Site-Specific Antimicrobial Susceptibility for Gram-Negative Bacteria: Identification of Significant Differences in Susceptibility, Intervention to Guide Empiric Therapy and Impact on Antimicrobial Consumption
49. Physical compatibility of vancomycin and piperacillin sodium–tazobactam at concentrations typically used during prolonged infusions
50. Need for standardization in assessing impact of antibiotic shortages on patient outcomes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.